Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Namrata B Kulkarni"'
Publikováno v:
SAGE Open Medicine, Vol 9 (2021)
Background: Venous thromboembolism is a significant source of morbidity and mortality following total hip replacement and total knee replacement. Apixaban has been proven to be efficacious without increased risk of bleeding in phase-III trials in pat
Externí odkaz:
https://doaj.org/article/03aec328262645668e361d71e083c2ad
Autor:
Prashant Shirish Ratnaparkhi, Namrata B Kulkarni, Meghana U Ganu, Sanjay G Godbole, Sudha Shrikant Deo
Publikováno v:
Journal of Diabetology, Vol 9, Iss 1, Pp 25-31 (2018)
Aim and Objective: Matrix metalloproteinases (MMPs) and Tribbles 3 (Trb3) human homologue have been reported to induce atherosclerosis. We wanted to evaluate the association of circulating levels of Trb3 human homologue and MMPs (MMP2 and MMP9), with
Externí odkaz:
https://doaj.org/article/0de1d1f855e7408d99d997b6bf0ecd2c
Autor:
B.K. Thelma, U M Thatte, Santosh R Taur, Namrata B. Kulkarni, Prajakta Gandhe, SH Ravat, Nithya J Gogtay
Publikováno v:
Journal of Postgraduate Medicine, Vol 60, Iss 3, Pp 265-269 (2014)
Background and Objective: Epilepsy, the most common neurological disorder, has treatment failure rate of 20 to 25%. Inter-individual variability in drug response can be attributed to genetic polymorphism in genes encoding different drug metabolizing
Publikováno v:
Therapeutic drug monitoring. 35(2)
Background: Therapeutic drug monitoring (TDM) is an important adjunct to the treatment of epilepsy. However, few studies have actually correlated plasma levels of antiepileptic drugs (AEDs) with treatment response. The present audit aimed to study (i